Matches in SemOpenAlex for { <https://semopenalex.org/work/W2044653048> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- W2044653048 endingPage "P03.052" @default.
- W2044653048 startingPage "P03.052" @default.
- W2044653048 abstract "Objective: Describe clinical and magnetic resonance imaging (MRI) characteristics of acute multiple sclerosis (MS) lesions with restricted diffusion preceding gadolinium (Gd) enhancement. Background Apparent diffusion coefficient (ADC) signal reduction in acute MS lesions has been reported, but the temporal pattern of gadolinium (Gd) enhancement relative to ADC changes has not been well described. Previous case reports either do not comment on Gd enhanced imaging or describe simultaneous Gd enhancement of lesions at the time of ADC reduction. We present three examples of acute MS lesions with decreased ADC followed by Gd enhancement. Design/Methods: Three patients (2 female, 1 male), ages 26-42, all with brain MRI studies within 48 hours of onset of acute neurological symptoms, were evaluated at our MS center within the past year. All underwent screening bloodwork and spine MRI, and 2 had cerebrospinal fluid (CSF) studies. Follow-up imaging was conducted approximately 1 month after initial MRIs. Results: Initial brain MRI revealed lesions in a location accounting for the new neurologic manifestations, >1 cm in diameter, and with prominent restricted diffusion but no Gd enhancement. The MS diagnoses were supported on the basis of CSF findings, laboratory exclusion of alternative diagnoses, lesion evolution, and additional lesions characteristic of MS on brain and/or spine MRI. All patients received IV methylprednisolone, 1000 mg daily for at least 3 days. Follow-up imaging at 1 month demonstrated patchy Gd enhancement throughout the lesions with resolving restricted diffusion. Two of 3 patients had additional follow-up imaging more than 1 month later which demonstrated total resolution of Gd enhancement. Conclusions: Although restricted diffusion without coincident Gd enhancement is most commonly associated with cerebral ischemia, acute MS lesions may demonstrate this pattern. The mechanism is uncertain but may reflect early demyelination prior to inflammation-associated blood-brain barrier disruption. Disclosure: Dr. Hyland has nothing to disclose. Dr. Bermel has received personal compensation for activities with Astellas, Biogen Idec, Novartis, and Teva Neuroscience as a consultant and/or speaker. Dr. Cohen has received personal compensation for activities with Biogen Idec, Eli Lilly & Company, Novartis, and Vaccinex. Dr. Cohen has received research support for activities with Biogen Idec, BioMS, Genzyme Corporation, Novartis, Synthon, and Teva Neuroscience." @default.
- W2044653048 created "2016-06-24" @default.
- W2044653048 creator A5002621424 @default.
- W2044653048 creator A5053403281 @default.
- W2044653048 creator A5083431100 @default.
- W2044653048 date "2012-04-22" @default.
- W2044653048 modified "2023-10-16" @default.
- W2044653048 title "Restricted Diffusion Preceding Gadolinium Enhancement in Acute Multiple Sclerosis Lesions (P03.052)" @default.
- W2044653048 doi "https://doi.org/10.1212/wnl.78.1_meetingabstracts.p03.052" @default.
- W2044653048 hasPublicationYear "2012" @default.
- W2044653048 type Work @default.
- W2044653048 sameAs 2044653048 @default.
- W2044653048 citedByCount "0" @default.
- W2044653048 crossrefType "journal-article" @default.
- W2044653048 hasAuthorship W2044653048A5002621424 @default.
- W2044653048 hasAuthorship W2044653048A5053403281 @default.
- W2044653048 hasAuthorship W2044653048A5083431100 @default.
- W2044653048 hasConcept C142724271 @default.
- W2044653048 hasConcept C178790620 @default.
- W2044653048 hasConcept C185592680 @default.
- W2044653048 hasConcept C203014093 @default.
- W2044653048 hasConcept C2780640218 @default.
- W2044653048 hasConcept C557651011 @default.
- W2044653048 hasConcept C71924100 @default.
- W2044653048 hasConceptScore W2044653048C142724271 @default.
- W2044653048 hasConceptScore W2044653048C178790620 @default.
- W2044653048 hasConceptScore W2044653048C185592680 @default.
- W2044653048 hasConceptScore W2044653048C203014093 @default.
- W2044653048 hasConceptScore W2044653048C2780640218 @default.
- W2044653048 hasConceptScore W2044653048C557651011 @default.
- W2044653048 hasConceptScore W2044653048C71924100 @default.
- W2044653048 hasIssue "Meeting Abstracts 1" @default.
- W2044653048 hasLocation W20446530481 @default.
- W2044653048 hasOpenAccess W2044653048 @default.
- W2044653048 hasPrimaryLocation W20446530481 @default.
- W2044653048 hasRelatedWork W1991624007 @default.
- W2044653048 hasRelatedWork W2000171744 @default.
- W2044653048 hasRelatedWork W2050215648 @default.
- W2044653048 hasRelatedWork W2150012525 @default.
- W2044653048 hasRelatedWork W2460698223 @default.
- W2044653048 hasRelatedWork W2617222556 @default.
- W2044653048 hasRelatedWork W2749743910 @default.
- W2044653048 hasRelatedWork W4200106809 @default.
- W2044653048 hasRelatedWork W4284889303 @default.
- W2044653048 hasRelatedWork W4295962679 @default.
- W2044653048 hasVolume "78" @default.
- W2044653048 isParatext "false" @default.
- W2044653048 isRetracted "false" @default.
- W2044653048 magId "2044653048" @default.
- W2044653048 workType "article" @default.